<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04148729</url>
  </required_header>
  <id_info>
    <org_study_id>ESP block in Spinal Surgery</org_study_id>
    <nct_id>NCT04148729</nct_id>
  </id_info>
  <brief_title>USG Guided ESP Block in Spinal Surgery</brief_title>
  <official_title>Effect of USG Guided ESP Block in Spinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      American Society of Anaesthesiologist physical status I-II, aged between 18-65, 60 patients
      which underwent lumbar spinal surgery will recruited to this study. These subjects will
      Ultrasound (USG) guided erector spinae block will perform at T10 level (bilaterally) to the
      all patient under general anaesthesia. 15 ml bupivacaine %0.5 and 5 ml lidocaine %2 will use
      for USG guided ESP block. 0.1 microgram/kg morphine will apply intravenously for
      postoperative analgesia to all patients. Postoperative pain assessment will perform with
      11-point numerical rating scale and morphine consumption will record .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      American Society of Anaesthesiologist physical status I-II, aged between 18-65, 60 patients
      which underwent lumbar spinal surgery will recruited to this study. The patients were
      randomly allocated into two groups (1:1), via a computer-generated randomization list.
      Ultrasound (USG) guided erector spinae block will perform at T10 level (bilaterally) to the
      30 patients under general anaesthesia in Group E and same volume saline will apply to the ESP
      block region at T10 level for control group (Group C). Total intravenous anaesthesia
      (propofol+remifentanil) will perform to the all patients. 15 ml bupivacaine %0.5 and 5 ml
      lidocaine %2 will use for USG guided ESP block. 0.1 microgram/kg morphine intravenously and
      diclofenac Na 75 mg intramuscularly will apply for postoperative analgesia to the all
      patients at last 30 minutes of surgery. Postoperative pain assessment will perform with
      11-point numerical rating scale (NRS). NRS, morphine consumption and complications will
      record. If the NRS higher than 4 rescue analgesic 0.4 mg/kg mepheridine will administer
      intravenously. Diclofenac sodium 75 mg will repeat to the all patients at the 12th of
      postoperative period, intramuscularly.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2019</start_date>
  <completion_date type="Anticipated">July 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 20, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Both participants and anaesthesia providers will not know contain of the syringe.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>11-point numerical rating scale score (NRS score)</measure>
    <time_frame>up the postoperative 24th hours.</time_frame>
    <description>Postoperative pain assessment will perform with 11-point numerical rating scale score and numerical scale point which described by resident will record. Higher points show that severe pain. 0 point shows no pain.10 point shows unbearable pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative analgesic requirement</measure>
    <time_frame>up the postoperative 24th hours.</time_frame>
    <description>When the higher points numerical scale point (4&lt;) observed, additional analgesics will apply. An than, totally consumption of rescue analgesic requirement (meperidine consumotion) will calculate.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>bupivacaine+lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 ml bupivacaine+ 5 ml lidocaine will use for USG guided ESP block under general anaesthesia with Sevuflurane and remifentanil. This block will perform at the T10 level bilaterally after induction of anaesthesia at the prone position. The patients will receive Morphine 0.1 microgram/kg intravenously and diclofenac sodium 75 mg intramuscularly at the last 30th minute of surgery. Postoperative pain assessment will perform with 11-point numerical rating scale. If the score over 4 points, rescue analgesic 0.4 mg/kg meperidine will be apply intravenously.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>saline</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>In this group, the same volume saline will apply to the block region. The patients will receive Morphine 0.1 microgram/kg intravenously and diclofenac sodium 75 mg intramuscularly at the last 30th minute of surgery. Postoperative pain assessment will perform with 11-point numerical rating scale. If the score over 4 points, rescue analgesic 0.4 mg/kg meperidine will be apply intravenously.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ESP block</intervention_name>
    <description>Ultrasound guided ESP block will perform with 15 ml bupivacaine+ 5 ml lidocaine at the T10 level bilaterally.</description>
    <arm_group_label>bupivacaine+lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control Group</intervention_name>
    <description>In this group Ultrasound guided ESP block will not perform. Postoperative analgesia will provide with 0.1 microgram morphine.</description>
    <arm_group_label>saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  accepting to participate the study

          -  ASA I-II patients

          -  The patients underwent spinal surgery

        Exclusion Criteria:

          -  Non Volunteers

          -  ASA III and over

          -  Renal and hepatic failure

          -  Emergency surgical procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ebru Biricik</last_name>
    <phone>05052420223</phone>
    <email>ebrubiricik01@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Feride Karacaer</last_name>
    <phone>05062628416</phone>
    <email>feridekaracaer@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ã‡ukurova University</name>
      <address>
        <city>Adana</city>
        <state>In The USA Or Canada, Please Select...</state>
        <zip>01380</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ebru Biricik</last_name>
      <phone>5052420223</phone>
      <email>ebrubiricik01@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 1, 2018</study_first_submitted>
  <study_first_submitted_qc>October 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2019</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>ebru biricik</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>erector spinae plane block</keyword>
  <keyword>postoperative analgesia</keyword>
  <keyword>spinal surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

